Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07ODD
|
|||
Former ID |
DNC000522
|
|||
Drug Name |
DC-015
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H25N5O2
|
|||
Canonical SMILES |
COC1=CC=CC=C1N2CCN(CC2)CC3CNC4=C5C=CC=CC5=NC(=O)N34
|
|||
InChI |
1S/C22H25N5O2/c1-29-20-9-5-4-8-19(20)26-12-10-25(11-13-26)15-16-14-23-21-17-6-2-3-7-18(17)24-22(28)27(16)21/h2-9,16,23H,10-15H2,1H3
|
|||
InChIKey |
COCJIISORPXDPN-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 149847-87-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adrenergic receptor Alpha-1 (ADRA1) | Target Info | Antagonist | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Antihypertensive and Hypolipidemic Effects of DC-015, a Novel, Potent and Specific alpha(1)-Adrenoceptor Antagonist: Comparison with Prazosin in Spontaneously Hypertensive Rats. J Biomed Sci. 1996 Apr;3(2):108-116. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.